Cabaletta Bio, Inc. (CABA)
2.91
-0.36
(-11.01%)
USD |
NASDAQ |
Sep 09, 16:00
2.91
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Price : 2.91 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 3.28 | 3.28 | 2.90 | 2.91 | 6.514M |
| Sep 08, 2026 | 3.43 | 3.48 | 3.26 | 3.27 | 3.071M |
| Sep 04, 2026 | 3.46 | 3.60 | 3.40 | 3.47 | 4.893M |
| Sep 03, 2026 | 3.63 | 3.75 | 3.47 | 3.48 | 7.437M |
| Sep 02, 2026 | 3.27 | 3.58 | 3.25 | 3.57 | 8.049M |
| Sep 01, 2026 | 3.00 | 3.315 | 2.84 | 3.30 | 6.648M |
| Aug 31, 2026 | 3.105 | 3.205 | 3.08 | 3.11 | 3.030M |
| Aug 28, 2026 | 3.36 | 3.375 | 3.11 | 3.12 | 3.239M |
| Aug 27, 2026 | 3.24 | 3.445 | 3.23 | 3.38 | 3.801M |
| Aug 26, 2026 | 3.20 | 3.27 | 3.17 | 3.25 | 2.486M |
| Aug 25, 2026 | 3.14 | 3.279 | 3.11 | 3.22 | 3.971M |
| Aug 24, 2026 | 3.09 | 3.17 | 3.01 | 3.10 | 3.108M |
| Aug 21, 2026 | 3.20 | 3.34 | 3.085 | 3.13 | 4.405M |
| Aug 20, 2026 | 3.04 | 3.24 | 2.95 | 3.19 | 5.738M |
| Aug 19, 2026 | 2.95 | 3.275 | 2.925 | 3.10 | 10.45M |
| Aug 18, 2026 | 2.89 | 2.96 | 2.82 | 2.91 | 6.982M |
| Aug 17, 2026 | 2.76 | 2.995 | 2.715 | 2.89 | 7.914M |
| Aug 14, 2026 | 2.68 | 2.77 | 2.64 | 2.75 | 2.352M |
| Aug 13, 2026 | 2.85 | 2.89 | 2.70 | 2.71 | 3.099M |
| Aug 12, 2026 | 2.742 | 2.87 | 2.742 | 2.85 | 2.807M |
| Aug 11, 2026 | 2.82 | 2.835 | 2.735 | 2.79 | 3.527M |
| Aug 10, 2026 | 2.78 | 2.83 | 2.74 | 2.80 | 2.775M |
| Aug 07, 2026 | 2.80 | 2.82 | 2.74 | 2.79 | 2.698M |
| Aug 06, 2026 | 2.68 | 2.82 | 2.66 | 2.76 | 2.742M |
| Aug 05, 2026 | 2.77 | 2.825 | 2.64 | 2.71 | 10.23M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.86 |
| Amgen, Inc. | 391.27 |
| Anika Therapeutics, Inc. | 20.88 |
| BioCryst Pharmaceuticals, Inc. | 8.805 |
| Imunon, Inc. | 1.51 |
Price Related Metrics
| Price to Book Value | 2.318 |
| Earnings Yield | -54.36% |
| Market Cap | 488.08M |